NCT02233218

The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

A Phase 1, Open Label, Non-randomized, Two-cohort, Single-sequence, Crossover Study to Investigate the Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: Male
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

To investigate the pharmacokinetic Drug-drug interaction

Detailed description

The purpose of this study is to investigate the pharmacokinetic Drug-Drug(telmisartan, amlodipine and/ or rosuvastatin) interaction and safety in healthy male volunteers.

Conditions

• Healthy Male Volunteer

Interventions

Type	Name	Description
DRUG	Telmisartan
DRUG	Amlodipine
DRUG	Rosuvastatin

Timeline

• Start date: 2014-07-01
• Primary completion: 2014-10-01
• Completion: 2015-01-01
• First posted: 2014-09-08
• Last updated: 2015-02-18

Locations

1 site across 1 country: South Korea